Neuropsychiatric Symptoms in Patients With Alzheimer’s Disease During SARS-COV-2 Pandemic in Peru

To evaluate neuropsychiatric symptoms in patients with Alzheimer’s disease (AD) and their association with cognition and functionality during lockdown of the COVID-19’s first wave. We included 91 patients and caregivers of people with AD from a memory clinic. The RUDAS, M@T, and CDR were administered to patients and NPI/ADCS-ADL to caregivers. Baseline and lockdown measurements scales were analyzed to compare the frequencies at baseline versus lockdown and conditional Odds Ratio (ORc) was calculated for the neuropsychiatric symptoms. During the pandemic, significant increase in the number of cases was observed in depression (23%), agitation (36.8%), aberrant motor activity (12%), sleep disorders (26.3%), and appetite change (12.1%). In worsening of pre-existing symptoms, the most frequent were delusions (75%), followed by sleep disorders (71.7%). Lockdown induces a rapid increase of neuropsychiatric symptoms affecting cognitive symptoms and functionality of Peruvian patients with AD.

[1]  F. Assogna,et al.  Effectiveness of a Family Support Intervention on Caregiving Burden in Family of Elderly Patients With Cognitive Decline After the COVID-19 Lockdown , 2021, Frontiers in Psychiatry.

[2]  H. Wood Elevated risk of COVID-19 in people with dementia , 2021, Nature Reviews Neurology.

[3]  M. Gurney,et al.  COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[4]  M. Filippi,et al.  The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey , 2021, Frontiers in Aging Neuroscience.

[5]  L. Pantoni,et al.  The impact of lockdown during SARS-CoV-2 outbreak on behavioral and psychological symptoms of dementia , 2021, Neurological Sciences.

[6]  R. M. Manero,et al.  Effects of COVID-19 Pandemic Confinement in Patients With Cognitive Impairment , 2020, Frontiers in Neurology.

[7]  A. Ruiz,et al.  Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia , 2020, Frontiers in Aging Neuroscience.

[8]  A. Venneri,et al.  The Impact of COVID-19 Infection and Enforced Prolonged Social Isolation on Neuropsychiatric Symptoms in Older Adults With and Without Dementia: A Review , 2020, Frontiers in Psychiatry.

[9]  R. Bernabei,et al.  Neuropsychiatric Symptoms in Elderly With Dementia During COVID-19 Pandemic: Definition, Treatment, and Future Directions , 2020, Frontiers in Psychiatry.

[10]  M. Filippi,et al.  Behavioral and Psychological Effects of Coronavirus Disease-19 Quarantine in Patients With Dementia , 2020, Frontiers in Psychiatry.

[11]  H. Graviotto,et al.  COVID-19 and the forgotten pandemic: follow-up of neurocognitive disorders during lockdown in Argentina. , 2020, Neurologia.

[12]  G. Logroscino,et al.  Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy. , 2020, Journal of Alzheimer's disease : JAD.

[13]  D. Kapogiannis,et al.  The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis. , 2020, Journal of Alzheimer's disease : JAD.

[14]  E. Mori,et al.  The behavioral pattern of patients with frontotemporal dementia during the COVID-19 pandemic , 2020, International Psychogeriatrics.

[15]  M. Cesari,et al.  Facing Dementia During the COVID‐19 Outbreak , 2020, Journal of the American Geriatrics Society.

[16]  Robin I. M. Dunbar,et al.  The Neurobiology of Social Distance , 2020, Trends in Cognitive Sciences.

[17]  I. Benítez,et al.  Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown , 2020, European journal of neurology.

[18]  G. Chowell,et al.  Early transmission dynamics of COVID-19 in a southern hemisphere setting: Lima-Peru: February 29th–March 30th, 2020. , 2020, medRxiv.

[19]  Antonio Cuesta-Vargas,et al.  Telehealth Home Support During COVID-19 Confinement for Community-Dwelling Older Adults With Mild Cognitive Impairment or Mild Dementia: Survey Study , 2020, Journal of medical Internet research.

[20]  Ashlyn M Jendro,et al.  Facetime to reduce behavioral problems in a nursing home resident with Alzheimer's dementia during COVID-19 , 2020, Psychiatry Research.

[21]  M. Fiorino,et al.  Access to Care for Dementia Patients Suffering From COVID-19 , 2020, The American Journal of Geriatric Psychiatry.

[22]  José Luis Molinuevo,et al.  Dementia care during COVID-19 , 2020, The Lancet.

[23]  David G. Rand,et al.  Using social and behavioural science to support COVID-19 pandemic response , 2020, Nature Human Behaviour.

[24]  Maxwell Z. Wilson,et al.  The impact of SARS‐CoV‐2 in dementia across Latin America: A call for an urgent regional plan and coordinated response , 2020, Alzheimer's & dementia.

[25]  G. Hérnandez-Córdova,et al.  Validation of the RUDAS in Patients With a Middle-Level Education in Lima, Peru , 2019, American journal of Alzheimer's disease and other dementias.

[26]  D. Aarsland,et al.  Course of neuropsychiatric symptoms in dementia: 5‐year longitudinal study , 2018, International journal of geriatric psychiatry.

[27]  N. Custodio,et al.  Memory Alteration Test to Detect Amnestic Mild Cognitive Impairment and Early Alzheimer’s Dementia in Population with Low Educational Level , 2017, Front. Aging Neurosci..

[28]  C. Lyketsos,et al.  Assessment and management of behavioral and psychological symptoms of dementia , 2015, BMJ : British Medical Journal.

[29]  Patricia Cortijo,et al.  The Memory Alteration Test Discriminates between Cognitively Healthy Status, Mild Cognitive Impairment and Alzheimer's Disease , 2014, Dementia and Geriatric Cognitive Disorders Extra.

[30]  David S. Miller,et al.  Neuropsychiatric symptoms in Alzheimer’s disease , 2011, Alzheimer's & Dementia.

[31]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[32]  R. Robinson,et al.  The construct of minor and major depression in Alzheimer's disease. , 2005, The American journal of psychiatry.

[33]  C. Lyketsos,et al.  Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. , 2002, JAMA.

[34]  J. Mintzer,et al.  Anxiety in the Behavioral and Psychological Symptoms of Dementia , 2000, International Psychogeriatrics.

[35]  David C. Steffens,et al.  Mental and behavioral disturbances in dementia: Findings from the cache county study on memory in aging , 2000, Neurobiology of Aging.

[36]  J. Cummings,et al.  Assessing the Impact of Neuropsychiatric Symptoms in Alzheimer's Disease: The Neuropsychiatric Inventory Caregiver Distress Scale , 1998, Journal of the American Geriatrics Society.

[37]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[38]  G. Arbanas Diagnostic and Statistical Manual of Mental Disorders (DSM-5) , 2015 .

[39]  M. Sano,et al.  An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease , 1997, Alzheimer disease and associated disorders.